Hybrid-capture NGS for broad solid cancer and MSI analysis. Offered by Genient Technologies as part of its expanded Oncology NGS portfolio.
A hybrid-capture epicGEN NGS kit for broad oncology marker coverage, combining solid cancer mutation analysis with MSI assessment.
A quick view of the product fit, marker scope, and workflow notes for laboratory planning.
RUO. Availability and intended use can vary by market; contact Genient for current guidance.
44 genes + 13 MSI
Isolated DNA sequencing workflow support.
GENOVESA cloud workflow support for FASTQ analysis and reporting discussions.
Our team can help with assay selection, availability, implementation planning, and sequencing workflow fit.
